There was a significant difference in the KIT mutation rate among GIST patients in the Ki67 status group of ≤5, group of >5 and <10, and group of ≥10 (p = 0.001333) (Table 4). The gene discussed is KIT; the disease is gastrointestinal stromal tumor.